Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy

Epilepsia

Volumn 51, Issue 10, 2010, Pages 1963-1969

  Halász, Peter ^a   Cramer, Joyce A ^b   Hodoba, Danilo ^c   Czåonkowska, Anna ^d   Guekht, Alla ^e   Maia, Joana ^f   Elger, Christian ^g   Almeida, Luis ^h,i   Soares Da Silva, Patricio ^f  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Zagreb   (Croatia)

^d INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^e PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^f DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITY OF AVEIRO   (Portugal)

ⁱ UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antiepileptic drugs; Epilepsy; Eslicarbazepine acetate; Long term treatment; Partial onset seizures; Quality of life

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ESLICARBAZEPINE ACETATE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DEPRESSION; DIPLOPIA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; RHINOPHARYNGITIS; SOMNOLENCE; TREATMENT RESPONSE; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; DIBENZAZEPINES; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG TOXICITY; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; HEALTH STATUS; HUMANS; INTENTION TO TREAT ANALYSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 78649248897     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02660.x     Document Type: Article

References (16)

1. Almeida L, Soares-da-Silva P,. (2007) Eslicarbazepine acetate (BIA 2-093). Neurotherapeutics 4: 88-96.
2. Almeida L, Bialer M, Soares-da-Silva P,. (2009) Eslicarbazepine acetate. In, Shorvon S, Perucca E, Engel J, (Eds) The Treatment of Epilepsy. Blackwell Publishing, Oxford, pp. 485-498.
3. Bender RA, Soleymani SV, Brewster AL, Nguyen ST, Beck H, Mathern GW, Baram TZ,. (2003) Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J Neurosci 23: 6826-6836.
4. Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P,. (1999) Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5- carboxamide derivatives. J Med Chem 42: 2582-2587.
5. Ben-Menachem E, Gabbai A, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P,. (2008) Efficacy and safety of eslicarbazepine acetate (ESL) as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-302 study. Epilepsia 49 (suppl 7): 424-425.
6. Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann BP,. (1998) Development and cross-cultural translation of a 31-item quality of life questionnaire (QOLIE-31). Epilepsia 39: 81-88.
7. Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P,. (2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 48: 497-504.
8. Elger C, Halasz P, Maia J, Almeida L, Soares-da-Silva P,. (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 50: 454-463.
9. Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P,. (2009) Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand 120: 281-287.
10. Hainzl D, Parada A, Soares-da-Silva P,. (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 44: 197-206.
11. Montgomery SA, Asberg M,. (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
12. Potschka H, Pekcec A, Soares-da-Silva P,. (2007) Inhibition of kindling progression by eslicarbazepine acetate and licarbazepine. Proceedings of the 27th International Epilepsy Congress, Singapore:Abstract Book.
13. Remy S, Beck H,. (2006) Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129: 18-35.
14. Remy S, Gabriel S, Urban BW, Dietrich D, Lehmann TN, Elger CE, Heinemann U, Beck H,. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53: 469-479.
15. Shah MM, Anderson AE, Leung V, Lin X, Johnston D,. (2004) Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44: 495-508.
16. Silver JM, Shin C, McNamara JO,. (1991) Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 29: 356-363.